---
uid: 20260215135508
title: Μεταβολομική Ανάλυση
authors: Dr. Tsoukalas (Metabolomic Medicine)
year: ~2018
url: https://www.drtsoukalas.com/metabolomiki_analisi-su-130.html
tags: [lit, dt-clinic, metabolomics, biomarkers, organic-acids, fatty-acids, amino-acids, precision-medicine, #ir-biomarker, #phd-biomarker, #gc-ms, #vitD, #adipic]
aliases: [Metabolomics_Analysis_Tsoukalas]
status: lit-full
parent-moc: [[55-MOCs/Literature]] | [[22-Dashboards/PhD_IR_MOC]]
confidence: high
cited_refs: [Refs_BMJ_Micronuts_COVID_043, Refs_Harvard_Fingerprints_Diabetes_044, Refs_Metabolic_Profiling_OrganicFatty_045, Refs_Metabonomic_Fingerprints_PlasmaUrine_046, Refs_Fathoming_Metabolism_Harvard_047, Refs_Holler_Micronutrient_Status_048, Refs_Metabolomics_Fundamentals_049, Refs_Sharpening_Precision_Medicine_050, Refs_Urinary_Organic_Acids_Asthma_051, Refs_Application_Metabolomics_OrganicAcids_052, Refs_Application_Metabolomics_FattyAcids_053, Refs_Targeted_Metabolomic_SerumFatty_Autoimmune_054, Refs_Metabolomics_Oncology_055]
---

# Metabolomics_Analysis_Tsoukalas_20260215_005 (Tsoukalas, ~2018)

**Source**: Dr. Tsoukalas (GR→EN RON extract). **Edits**: Fluff stripped; zettel claims hubbed.

## TL;DR (Actionable)
- Metabolomics studies metabolites (org acids/fatty/amino/sugars) in urine/plasma/serum/saliva/hair for chronic disease biomarkers.
- 174 metabolites tested; precision medicine via individual metab fingerprint.
- Biomarkers for cancer/diabetes/autoimmunity; GC-MS adipic/IR/VitD PhD hooks.
- Urine/plasma reliable for fatty acids/org acids; hair for long-term.

## Full Extract
**Core Thesis**: Metabolomics analysis (174 metabolites: org acids, fatty acids, amino acids, sugars) in biofluids (urine/plasma/serum/saliva/hair) diagnoses chronic diseases; precision Rx.

**Markers**: Org acids (metab disorders), fatty acids (autoimmune), amino (nutrition), sugars (diabetes).

**Biofluids**: Urine/plasma short-term; hair cumulative.

## Linked References (13 total)
- [[Refs_BMJ_Micronuts_COVID_043]] (Tsoukalas & Sarandi 2021 | | Tier:2 | Micronutrient deficiencies in COVID-19 patients; metabolomics role in prevention/replenishment.)
- [[Refs_Harvard_Fingerprints_Diabetes_044]] (Harvard Magazine 2011 | | Tier:4 | Metabolic fingerprints for diabetes and other diseases via Harvard research.)
- [[Refs_Metabolic_Profiling_OrganicFatty_045]] (Sarandi E, Tsoukalas D et al. 2020 | DOI:10.1016/j.acc.2020.04.004 | Tier:2 | Metabolic profiling of organic and fatty acids in chronic and autoimmune diseases.)
- [[Refs_Metabonomic_Fingerprints_PlasmaUrine_046]] (Zhao X et al. 2010 | DOI:10.1007/s11306-010-0203-1 | Tier:2 | Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits.)
- [[Refs_Fathoming_Metabolism_Harvard_047]] (Harvard Magazine 2011 | | Tier:4 | Harvard research on metabolism via metabolomics.)
- [[Refs_Holler_Micronutrient_Status_048]] (Höller U et al. 2018 | | Tier:2 | Micronutrient status assessment in humans: current methods of analysis and future trends.)
- [[Refs_Metabolomics_Fundamentals_049]] (Sussulini A (ed.) 2017 | | Tier:3 | Metabolomics: From Fundamentals to Clinical Applications.)
- [[Refs_Sharpening_Precision_Medicine_050]] (Beebe K, Kennedy AD 2016 | | Tier:3 | Sharpening Precision Medicine by a Thorough Interrogation of Metabolic Individuality.)
- [[Refs_Urinary_Organic_Acids_Asthma_051]] (Papamichael MM et al. 2018 | DOI:10.1016/j.nutres.2018.10.004 | Tier:3 | Urinary organic acids as biomarkers in the assessment of pulmonary function in children with asthma.)
- [[Refs_Application_Metabolomics_OrganicAcids_052]] (Tsoukalas D et al. 2017 | PMID:28498405 | Tier:2 | Application of metabolomics: Focus on the quantification of organic acids in healthy adults.)
- [[Refs_Application_Metabolomics_FattyAcids_053]] (Tsoukalas D et al. 2019 | PMID:30431095 | Tier:2 | Application of metabolomics part II: Focus on fatty acids and their metabolites in healthy adults.)
- [[Refs_Targeted_Metabolomic_SerumFatty_Autoimmune_054]] (Tsoukalas D et al. 2019 | DOI:10.3389/fmolb.2019.00120 | Tier:2 | Targeted Metabolomic Analysis of Serum Fatty Acids for the Prediction of Autoimmune Diseases.)
- [[Refs_Metabolomics_Oncology_055]] (Unknown (Tsoukalas PDF) | | Tier:4 | Metabolomics in oncology biomarkers.)

## Extracted Atomics (8 dynamic zettels)
- [[Metabolomics_Metabolite_Study_20260215_036]] (Metabolomics systematically studies metabolites—organic acids, fatty acids, amino acids, sugars—in biofluids to identify disease biomarkers.)
- [[Biofluids_UrinePlasmaHair_20260215_037]] (Urine/plasma/serum/saliva capture short-term metabolite changes; hair provides long-term cumulative profiles for chronic disease biomarkers.)
- [[174_Metabolites_Test_20260215_038]] (Tsoukalas clinic tests 174 metabolites (org acids/fatty/amino/sugars) via metabolomics for comprehensive chronic disease profiling.)
- [[OrgAcids_MetabDisorders_20260215_039]] (Urinary organic acids serve as biomarkers for metabolic disorders, detected via GC-MS in metabolomics analysis.)
- [[FattyAcids_Autoimmune_20260215_040]] (Fatty acid profiles in plasma/serum reveal autoimmune disease biomarkers via targeted metabolomics.)
- [[Precision_Medicine_Metab_20260215_041]] (Metabolomics enables precision medicine by generating individual metabolic fingerprints from 174-metabolite panels.)
- [[GC-MS_Adipic_Biomarker_20260215_042]] (GC-MS detects adipic acid in urine as a key biomarker for metabolic dysfunction, IR, VitD issues (PhD chain).)
- [[Metabolomics_CancerDiabetes_20260215_043]] (Metabolomics identifies biomarkers for cancer and diabetes via metabolite dysregulation (sugars, fatty/org acids).)

**RON Ledger**: Input=URL → 13 refs + 8 atomics + 1 MOC. PhD: Metabolomics adipic/IR/VitD.
**Next**: [[55-MOCs/MOC_DT_Metabolomics_Analysis_20260215_005]] | [[33-Atomic/Adipic_Metabolomics_Protocol_20260215_044]].